hank_denver said:Worth knowing that the injection site changes very little.
Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.
hank_denver said:Worth knowing that the injection site changes very little.
Genuinely useful, thank you. I had the facts and not the framework. I will report back once I have actually tried it.
Clinical perspective, offered as context rather than as advice. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.
Correct me if the detail matters more than I have assumed.
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesEst. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemDr.SportsMedIN said:It is worth asking what the claim would look like if it were false.
This matches mine closely enough to be worth saying so out loud. The detail I would add is minor and it is already implied above.
Dr.SportsMedIN said:It is worth asking what the claim would look like if it were false.
Coming at Dr.SportsMedIN’s question from a different direction. The mechanism that matters here is not stomach emptying, it is central. GLP-1 receptor agonism in the arcuate nucleus stimulates POMC neurons and suppresses AgRP/NPY signalling, which is why the effect is appetite and food salience rather than physical fullness. Delayed gastric emptying largely tachyphylaxes over the first months; the appetite effect does not.